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Abstract
Background: Myogenesis in C2C12 cells requires the activation of the PI3K/mTOR signaling pathways. Since mTOR 
signaling can feedback through S6K1 to inhibit the activation of PI3K, the aim of this work was to assess whether 
feedback from S6K1 played a role in myogenesis and determine whether siRNA mediated knockdown of S6K1 would 
lead to an increased rate of myotube formation.
Results: S6K1 activity increased in a linear fashion following plating and was more than 3-fold higher after Day 3 of 
differentiation (subconfluent = 11.09 ± 3.05, Day 3 = 29.34 ± 3.58). IRS-1 levels tended to increase upon serum 
withdrawal but decreased approximately 2-fold (subconfluent = 0.88 ± 0.10, Day 3 = 0.42 ± 0.06) 3 days following 
differentiation whereas IRS-2 protein remained stable. IRS-1 associated p85 was significantly reduced upon serum 
withdrawal (subconfluent = 0.86 ± 0.07, Day 0 = 0.31 ± 0.05), remaining low through day 1. IRS-2 associated p85 
decreased following serum withdrawal (subconfluent = 0.96 ± 0.05, Day 1 = 0.56 ± 0.08) and remained suppressed up 
to Day 3 following differentiation (0.56 ± 0.05). Phospho-tyrosine associated p85 increased significantly from 
subconfluent to Day 0 and remained elevated throughout differentiation. siRNA directed against S6K1 and S6K2 did 
not result in changes in IRS-1 levels after either 48 or 96 hrs. Furthermore, neither 48 nor 96 hrs of S6K1 knockdown 
caused a change in myotube formation.
Conclusions: Even though S6K1 activity increases throughout muscle cell differentiation and IRS-1 levels decrease 
over this period, siRNA suggests that S6K1 is not mediating the decrease in IRS-1. The decrease in IRS-1/2 associated 
p85 together with the increase in phospho-tyrosine associated p85 suggests that PI3K associates primarily with 
scaffolds other than IRS-1/2 during muscle cell differentiation.
Background
During development, multinucleated muscle fibers form
from the terminal differentiation and fusion of individual
myogenic progenitors, or myoblasts [1]. This process is
recapitulated during the process of skeletal muscle regen-
eration in response to trauma, disease, or contraction
mediated injury [2]. As a result of the importance of this
process, the regulation of myoblast differentiation and
fusion has been widely studied in tissue culture using
both primary and transformed myoblasts. In 2-dimen-
sional cell culture, myoblasts are maintained in a prolifer-
ative state by providing media with high serum content
and maintaining a relatively low confluence. Growing the
myoblasts to full confluence or changing to a low serum
growth media induces terminal differentiation. The com-
bination of high confluence and low serum growth media
induces both myoblast differentiation and fusion, result-
ing in the formation of myotubes.
Myogenesis is regulated at multiple levels. The degree
of confluence and the level of growth factors within the
media are transduced by a series of kinase signaling path-
ways [3]. How myoblasts signal confluence is currently
unclear. At high confluence, cadherins are thought to sig-
nal to p38 MAPK either through a Rho kinase (ROCK)
[4] or Cdo/JLP dependent [5] mechanism. The activation
of p38 enhances the transcriptional activity of several
MRFs [6] and in this way may initiate myoblast differenti-
ation.
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Page 2 of 10Growth factor regulation of myogenesis is better
understood. When growth factors are low, myoblasts
begin to secrete IGF-II, which is required for, and deter-
mines, the rate of differentiation [7]. IGF-II is thought to
initiate an autocrine signaling cascade through the IGF-I
receptor [8] and the insulin receptor substrates (IRS) 1
and 2, that activates MAPK and PI3K (phosphoinositide-
3 kinase) [9]. PI3K activates PKB (protein kinase B/akt),
and either PI3K or PKB is sufficient for myoblast differ-
entiation and fusion [10]. PI3K and PKB drive differentia-
tion by inhibiting GSK3 [11], increasing the
transcriptional activity of MyoD [12], and activating the
mammalian target of rapamycin (mTOR; [13]. mTOR
expression and activity increase during differentiation
[14] leading to an increase in the activity of its down-
stream target, S6K1 [14,15]. However, neither the kinase
activity of mTOR nor S6K1 are required for differentia-
tion [16]. Even though S6K1 activity is not required for
muscle cell differentiation, S6K1 can regulate the activa-
tion of PKB by IGF-II through IRS-1 protein, mRNA, and
activity [17-19]. Where S6K1 is constitutively active, as in
TSC2-/- cells, IRS-1 function is potently suppressed [17].
Considering the important role of the IGF-II signaling
through IRS-1 to PKB in the control of differentiation,
and the ability of S6K1 to block IRS-1 signaling, it seems
paradoxical that S6K1 would be activated during differ-
entiation. The aim of the current work was to assess
whether the negative feedback between S6K1 and IRS-1
was maintained during myogenesis. We hypothesised
that the activation of S6K1 during differentiation would
correlate with a reduction in IRS-1 function and that
inhibiting S6K1 activation would increase myotube for-
mation.
Results
Myotube formation and muscle specific gene expression
Three hours after plating, the subconfluent cells attached
and spread to reach ~70% confluence (Figure 1). At Day
0, the cells formed a confluent monolayer. At Day 1, the
cells began to align and fuse and expressed low levels of
myosin heavy chain (Figure 1B). By Day 3 large numbers
of myotubes and high myosin heavy chain levels were evi-
dent. These time points were selected since the subcon-
fluent to Day 0 interval could be used to determine
contact-dependent events, the Day 0 to Day 1 interval
could be used to identify growth factor-dependent differ-
entiation events, and the 3 day point could be used to
determine the effects of an intervention on fusion.
The percentage of nuclei stained with MyoD or myo-
genin and the levels of myosin heavy chain were assessed
to give a measure of the stage of myogenesis. Nuclei
stained with MyoD increased approximately 2-fold upon
reaching confluence (Figure 1C; subconfluent = 22 ±
7.3%; versus Day 0 = 47 ± 5.1%), remained elevated once
growth factors were removed for 24 hrs (Day 1 = 46.8 ±
6.4%), and returned towards subconfluent levels follow-
ing another 48 hrs in DM (Day 3 = 31 ± 4.1%). Myogenin
expression increased progressively following plating,
peaking 72 hrs following serum withdrawal (Figure 1C).
Differentiation induced signaling
To begin to understand the dynamics of the signaling
events that may lead to differentiation, the phosphoryla-
tion of p44/42 at Thr202/Tyr204 and PKB at Thr308, and
the phosphorylation and activity of S6K1 were deter-
mined at the various stages of differentiation. The phos-
phorylation of p44/42 decreased significantly upon
reaching confluence and remained significantly sup-
pressed up to 72 hrs following serum withdrawal (Figure
2A). Phosphorylation of PKB on the other hand appears
to have a bi-phasic response. Upon reaching confluence,
PKB phosphorylation decreased approximately 3-fold
(SC = 0.87 ± 0.07, Day0 = 0.32 ± 0.02). From Day 0 to Day
1, PKB phosphorylation and total protein increased mar-
ginally (Day0 = 0.32 ± 0.02, Day 1 = 0.42 ± 0.02), and then
from Day 1 to Day 3, PKB phosphorylation decreased and
the total protein increased resulting in a large decrease in
the ratio of phospho- to total PKB (Day 3 = 0.15 ± 0.01;
Figure 2B). S6K1 phosphorylation and activity increased
approximately 3-fold from SC (11.10 ± 3.05) to Day 3
(29.33 ± 3.57; Figure 2C).
IRS-1/2 Expression and associated p85
To better understand the role that IRS-1 and IRS-2 play
in signaling during myogenesis, IRS1/2 protein level and
PI3K association were determined. IRS-2 protein (Figure
3B) remains stable throughout the time course, whereas
IRS-1 protein tended to increase to Day 1 before reducing
approximately 2-fold by Day 3 (subconfluent = 0.88 ±
0.10, Day 3 = 0.42 ± 0.06; Figure 3A). The association of
IRS-1 with p85 significantly reduced upon serum with-
drawal (subconfluent = 0.86 ± 0.07, Day 0 = 0.31 ± 0.05).
Even though the absolute amount of p85 precipitated
remain the same at Day 1 and 3, the decrease in total IRS-
1 protein at Day 3 leads to an increase in the amount of
p85 relative to IRS-1 (Figure 3C). IRS-2 associated p85
decreased from subconfluent levels reaching significance
on Day 1 (subconfluent = 0.96 ± 0.05, Day 1 = 0.56 ± 0.08)
and remained suppressed up to Day 3 (0.56 ± 0.05; Figure
3D). Therefore, reaching confluence reduces signaling
through IRS-1, while IRS-2 signaling reduces following
serum withdrawal.
Knockdown of S6K1 does not alter IRS-1 levels or 
differentiation
To determine whether increasing S6K1 activity underlies
the decrease in IRS-1 protein and activity, siRNA
directed against S6K1 and its homologue S6K2 were
transfected into muscle cells prior to differentiation.
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collected at Day 1) significantly reduced S6K1 protein
levels (Figure 4A). However, despite the robust knock-
down of S6K1 there was no effect on IRS-1 protein levels
(Figure 4B). To determine whether loss of S6K1 was com-
pensated for by its homologue S6K2, we knocked down
S6K2 individually or in combination with S6K1 and mea-
sured the effects on IRS-1 levels and differentiation.
Knock down of S6K2 or S6K1 and 2 had no effect on IRS-
1 protein levels (Figure 4B) or myotube formation (data
not shown). Since the decrease in IRS-1 protein was not
apparent until Day 3, the effects of a more sustained
knockdown (collecting the cells at Day 3) on IRS-1 levels
and differentiation were determined. The 96 hr knock-
down yielded similar results: no increase in IRS-1 protein
levels (Figure 4C) and no change in myotube formation
(Figure 4D). These data suggest that the physiological
activation of S6K1 does not mediate the decrease of IRS-
1 protein level during myoblast differentiation and has no
effect on myotube formation.
Differentiation-induced phosphotyrosine associated p85
Since PI3K signaling is known to be required for myotube
formation, yet IRS-1/2 associated p85 was decreased,
phospho-tyrosine associated p85 was determined to
assess non-IRS associated PI3K activation. pY associated
p85 increased approximately 2-fold (SC = 0.92 ± 0.05,
Day 0 = 1.93 ± 0.11; Figure 5) upon reaching confluence
and remained significantly elevated throughout the 72
hrs of the experiment (Day 3 = 1.84 ± 0.05). These data
suggest that PI3K is activated within the myoblasts upon
reaching confluence and that the predominant route for
PI3K signaling is through non-IRS-1/2 phospho-tyrosine
complexes.
Discussion
In C2C12 cells, S6K1 activity increased almost 3-fold
from subconfluence until myotubes were completely
formed. Concomitant with the increase in S6K1 activity
was a decrease in IRS-1 signaling and protein levels, con-
sistent with the negative feedback loop from S6K1 to IRS-
1. However, knocking down S6K1 had no effect on IRS-1
protein levels, suggesting that physiological activation of
S6K1 during differentiation did not lead to the reduction
of IRS-1 protein. Even though IRS-1/2 function decreases
during differentiation, phosphotyrosine associated p85
increases at confluence and remains high throughout dif-
ferentiation. These data suggest that during myogenesis
the predominant source of PI3K activity is phosphoty-
rosine complexes other than IRS-1/2.
S6K1 activity increases substantially from subconfluent
C2C12 myoblasts to fully differentiated myotubes.
Figure 1 Myotube formation and muscle specific gene expression. A) Representative phase contrast images of C2C12 cells 3hrs post plating (sub-
confluent; SC), 24 h post plating (Day 0), 24 h after achieving confluence (Day 1), or 72 hrs following differentiation (Day 3). B) Myosin heavy chain 
protein content at subconfluent (SC), 24 h post plating (Day 0), 24 h after achieving confluence (Day 1), or 72 hrs following differentiation (Day 3). C) 
Representative images of MyoD and myogenin immunohistochemistry and the quantification of positive nuclei. * indicates significantly different from 
subconfluent (SC) values.
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a negative feedback loop in insulin/growth factor signal-
ing [19]. This feedback is mediated through serine phos-
phorylation and direct regulation of IRS-1 protein and
mRNA. In differentiated L6 myotubes, activation of S6K1
for as little as 1hr, inhibits insulin stimulated IRS-1 asso-
ciated PI3K activity [18]. Therefore, we hypothesized that
the prolonged activation of S6K1 during myogenesis
would lead to a reduction in IRS-1 protein levels. Consis-
tent with this hypothesis, IRS-1 protein declined by more
than 50% between Day 1 and Day 3 of differentiation.
Since growth factor mediated differentiation is thought to
involve IGF-II signaling through IRS-1 to PI3K and PKB,
we further hypothesized that decreasing S6K1 would
increase IRS-1 protein and result in greater IGF-II signal-
ing and myoblast differentiation. Contrary to this hypoth-
esis, knockdown of S6K1, its structural homologue S6K2,
or both enzymes together had no effect on IRS-1 protein
level or muscle cell differentiation. These data suggest
that during differentiation S6K1 does not regulate the
level of IRS-1 protein or muscle cell differentiation. In
agreement with the current work, Park et al [16,20] have
elegantly shown that S6K1 is not required for muscle cell
differentiation but plays an important role in myocyte
hypertrophy once differentiation is complete.
Measuring the amount of p85 associated with a partic-
ular scaffolding protein provides an estimate of the PI3K
activity of that complex. Due to the requirement on IRS-1
for human myoblast differentiation [21] we had expected
that IRS-1 associated p85 would be substantially elevated
from the point of plating. However, both IRS-1 and IRS-2
associated p85 were significantly suppressed during dif-
ferentiation. Instead of associating with IRS-1 or 2, PI3K
associates with other phosphotyrosine complexes during
differentiation in C2C12 cells. These data do not preclude
a role for IRS in myogenesis. Indeed, cross-talk between
cell surface receptors and the insulin/IGF-I pathways has
recently been described in mice with skeletal muscle lack-
ing β1-integrins [22]. In mice without β1-integrins insu-
lin-induced phosphorylation of PKB at Ser473 was
impaired even though IRS-1 signaling appeared normal.
Since integrins and cadherins interact with integrin-
linked kinase (ILK;[23,24], and ILK binds to both PKB
and the Ser473 kinase mTORC2 [25], this suggests that
cell surface receptors work together with IRS-1 to acti-
vate PI3K and PKB. The current data suggest that in dif-
ferentiating muscle, the interaction between the cell
surface receptors and IRS-1 is reversed. At high conflu-
ence, cell-cell contact results in the activation of cad-
herins and integrins [26], which function as high
confluence-activated receptors. PI3K can be recruited to
cell-cell contacts and activated by cadherin [27], but this
has yet to be demonstrated in muscle cells. During differ-
entiation, cadherins are upregulated in C2C12 cells [28],
suggesting that they may play an important role in con-
fluence-dependent differentiation. Some researchers
Figure 2 Differentiation decreases p42/44 and PKB signaling 
whereas S6K activity increases. A) p44/42 MAPK Thr202/Tyr204 
phosphorylation relative to total p44/42 (p-p44/42), B) PKB Thr308 
phosphorylation relative to total PKB (p-PKB) and C) S6K1 phosphory-
lation and activity determined relative to total S6K1 3 hrs post plating 
(subconfluent; SC), 24 h post plating (Day 0), 24 h after achieving con-
fluence (Day 1), or 72 hrs following differentiation (Day 3). * indicates 
significantly different from SC, † indicates significantly different from 
Day 1. Values were obtained by normalising specific phosphorylation 
to total protein content as described in methods.
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differentiation, but this has previously been attributed to
Rho kinase [4] or Cdo/JLP [5] dependent activation of
p38. The current data suggest a more direct mode of acti-
vation is possible: the direct recruitment of PI3K, possi-
bly in association with a permissive level of activated IRS-
1, to the membrane and the local production of PIP3.
While the cadherins have yet to be definitively identified
as the phospho-tyrosine containing protein that increases
its interaction with p85 during differentiation, the loca-
tion, function, and dynamics of cadherins during differ-
entiation are all suggestive of a role for these proteins.
Our profile of PKB phosphorylation differs from that
previously published [29,30]. We observed a biphasic
response, whereas others observe a linear increase in PKB
phosphorylation at Ser473 and Thr308 [29,30]. This dis-
crepancy could be due to the differentiation protocol
used. We include data from cells at subconfluence and
withdraw serum at 90-100% confluence whilst Deldicque
et al [29] withdrew serum at 70% confluence. Gonzalez et
al. [31] include data from cells at subconfluence however
they collected their cells at a higher confluence and they
plated their cells on gelatin coated plates which could
affect the cell surface receptors that may be involved in
PKB activation. These differences may explain why Gon-
zalez et al. did not observe an initial reduction in PKB
Thr308 phosphorylation upon reaching confluence.
Using a similar protocol and measuring PKB activity
directly, Cuenda and Cohen observed the same increase
in PKB activity 1.5 days following serum withdrawal fol-
lowed by a decrease at day 3 [15]. These results highlight
the importance of maintaining a consistent protocol for
differentiation studies.
Conclusions
Reducing S6K1 protein in differentiating myoblasts does
not prevent the loss of IRS-1 at Day 3 of differentiation or
Figure 3 IRS-1/2 expression and associated p85 decrease throughout differentiation. A) IRS-1 and B) IRS-2 total protein was measured via west-
ern blots and normalised to relative eEF2 protein content and C) IRS-1 and D) IRS-2 associated p85 was determined as described in methods. All mea-
sures were made at 3 (subconfluent; SC), 24 (Day 0), 48 (Day 1), or 96 hours (Day 3) following plating. * indicates significantly different from SC, † 
indicates significantly different from all other time points, § indicates significantly different from SC and Day 0.
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are physiological situations when S6K1 is activated and
yet IRS-1 is not adversely affected. Furthermore, IRS-1/2
do not appear to contribute substantially to overall PI3K
activity during muscle cell differentiation, suggesting that
other, as yet undetermined proteins, mediate this essen-
tial aspect of muscle cell differentiation.
Figure 4 S6K1 siRNA knockdown does not affect IRS-1 protein or muscle cell differentiation. A) Representative Blots, B) IRS-1 and S6K1 expres-
sion following treatment with siRNA directed against S6K1 and S6K2 for 48hrs post transfection (cells transfected at SC and collected at Day 1), C) IRS-
1 and S6K1 levels relative to eEF2 following treatment with siRNA directed against S6K1 and S6K2 for 96 hrs (cells transfected at SC and collected at 
Day 3), D) Representative images of myotube formation following 96hrs siRNA treatment. Figure headings - SCR = scramble control siRNA, S6K1 = 
siRNA against S6K1, S6K2 = siRNA against S6K2, S6K1/2 = siRNA against both S6K1&2, SCR+Fl = scramble control plus a fluorescent tagged siRNA, NTC 
= no treatment control. * indicates significantly differently different from all other treatments.
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Materials
All plasticware for tissue culture was from Greiner
(VWR, UK). Tissue culture media and sera were from
Invitrogen. Anti-IRS-1 and anti-IRS-2 antibodies were
obtained from the Division of Signal Transduction Ther-
apy (DSTT; University of Dundee). pY20 was obtained
from BD Biosystems (New Jersey, USA). Total myosin
heavy chain (MF20) and the myogenin (F5D) antibodies
were obtained from the Developmental Studies Hybri-
doma Bank developed under the auspices of the NICHD
and maintained by The University of Iowa, Department
of Biological Sciences, Iowa City, IA 52242. Antibodies
for p-PKBT308, t-eEF2, S6KT389, p-p44/42Thr202/Tyr204, t-
p44/42, and t-PKB were from Cell Signaling Technologies
and were used at 1:1000. The total S6K antibody was
from Santa Cruz Biotechnologies and was used at 1:1000.
Secondary antibodies were from Perbio Science (Cram-
lington, UK) and used at 1:10000. All phospho-specfic
antibodies were quantified relative to their total protein,
whereas IRS-1/2 and MHC were quantified relative to
eEF2. Total eEF2 protein content was unchanged by any
of the treatment or interventions. Thr308 phosphoryla-
tion was used to measure the effects of differentiation of
PKB since this is the primary PI(3,4,5)P3-dependent site
[32] and therefore the most directly regulated by IRS-1/2.
Chemicals were from Sigma-Aldrich unless stated other-
wise.
Tissue culture and transfection
C2C12 myoblasts were grown in growth media [Dul-
becco's Modified Eagle's Medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin]. Myoblasts were kept below 60%
confluence to prevent confluence-induced differentia-
tion. Cells for immunohistochemistry were plated at
approximately 200000 cells/well in 6-well plates on colla-
gen coated coverslips and fixed after 3 hrs (subconfluent)
Figure 5 Differentiation increases phosphotyrosine associated p85. Representative western blot of phosphotyrosine associated p85 in C2C12 
cells at 3 (subconfluent; SC), 24 (Day 0), 48 (Day 1), or 96 hours (Day 3) following plating. Phosphotyrosine complexes were immunoprecipitated and 
the associated p85 was determined by western blot and quantified using the IgG HC as a control. * indicates significantly higher than in subconfluent 
cells.
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cells, the media was changed to differentiation media
(DMEM supplemented with 2% HS and 1% penicillin/
streptomycin). Cells were then fixed 24 hrs (Day 1) or 72
hrs (Day 3) following differentiation. Cells for immuno-
precipitations, kinase assays and western blots were
plated on 10 cm plates at 1.2 million cells per plate and
differentiated as above. Each experiment was performed
on three separate occasions with n = 4 for each experi-
ment. Data presented is representative data from a single
experiment.
RNA interference of S6K1 and S6K2
Specific siRNA was designed using the siGENOME
SMARTpool approach (Dharmocon RNAi Techonlogies,
Thermo Scientific, UK) based on the mouse sequence for
S6K1 (NM_028259) and S6K2 (NM_021485). Prior to
transfection with siRNA, cells were seeded on 12 well
plates at 80000 cells per well with the transfection carried
out 3 hours following seeding. Cells were washed × 3 with
sterile PBS and 1 ml serum and antibiotic free DMEM
was added to the cells prior to the addition of transfection
medium. The transfection medium consisted of 200 nmol
of siRNA and an equal amount (1:1) of lipofectamine
2000 reagent suspended in optimem transfection media
(Invitrogen, UK). siRNA was conjugated with lipo-
fectamine for 30 min before being added to the cells for
18 h. At the end of 18 hours, cells were washed × 3 with
PBS and moved to differentiation media. Mouse ON-
TARGETplus Non-targeting siRNA (# D-001810-10,
Dharmacon RNAi technologies) was used as a control
during all experiments, whilst siGLO (Dharmacon RNAi
technologies) was used to assess primary and secondary
transfection efficiency.
Protein extraction and SDS-PAGE
At the allocated time points, cells were washed with ice
cold PBS and lysed in sucrose lysis buffer (50 mM Tris
pH7.5, 250 mM Sucrose, 1 mM EDTA, 1 mM EGTA, 1%
Triton × 100, 50 mM NaF, 1 mM NaVO4 Na2(PO4)2 and
0.1% DTT). The lysate was briefly vortexed and centri-
fuged at 4°C for 10 mins at 11000 rpm to remove insolu-
ble material. Protein concentrations were determined
using the DC protein assay (Bio-Rad, Hercules CA).
Equal aliquots of protein were diluted in Laemmli sample
buffer and boiled for 5 mins. 5-10 μg of sample was then
subjected to SDS-PAGE on 10% acrylamide gels and
transferred to Protran nitrocellulose membrane (What-
man, Dassel, Germany) and blocked in 5% dry milk in
TBS-T.
Immunobloting
Membranes were incubated in phosphospecific antibod-
ies overnight at 4°C, washed and then incubated in HRP
conjugated secondaries at 1:10000 for 1 hr at room tem-
perature. Following a final wash, the membranes were
incubated in Immobilon™ Western Chemiluminescent
HRP Substrate (Millipore, Billerica, MA) and exposed in
a Chemigenius Bio-imaging System (Syngene, Cam-
bridge, UK). The membranes were then stripped in
Restore™ Western Blot Stripping Buffer (Pierce, Rockford,
IL) for 20 mins and reprobed for total protein content. All
phosphorylation specific antibodies were normalised to
the relevant total protein antibody when available, or to
eEF2 when this was not possible.
S6K1 activity assay
S6K1 activity was measured as previously described [33].
Briefly, endogenous S6K1 was immunoprecipitated
from1 mg total protein for 2 hours at 4°C with 1 μg of rab-
bit anti-S6K1. S6K1 protein was then immobilised on
protein-G sepharose for one hour. Immunocomplexes
were washed one time in high detergent buffer A (1% NP-
40, 100 mM NaCl, 10 mM Tris pH 7.2, 1 mM EDTA), two
times in high salt buffer B (1M NaCl, 0.1% NP-40, 10 mM
Tris pH 7.2), and one time in ST buffer (150 mM NaCl, 50
mM Tris pH 7.2). The immunocomplexes were resus-
pended in 20 μl of 1.5 × kinase buffer (200 mM Hepes pH
7.2, 100 mM MgCl2, 1 mg/ml BSA. 1:3000 2-Mercapto-
ethanol) and the activity towards a recombinant GST-S6
peptide was assayed for 10 mins at 30°C. Reactions were
initiated and terminated using 10 μl ATP mix (50 μM
unlabelled ATP, 5 μCi of [γ-32P] ATP, 1 μl GST-S6) and 4
× LSB (0.5 M Tris pH 6.8, 0.8% SDS, 20% 2-Mercaptoeth-
anol, 30% Glycerol), respectively. Reactions were sub-
jected to 10% SDS-PAGE and incorporation of 32P into
GST-S6 was assessed by autoradiography and quantified
using a Chemi Genius Bioimaging Gel Doc System (Syn-
gene, Cambridge, UK).
Immunocytochemistry
Coverslips containing cells (see above) were rinsed twice
in room temperature PBS before being fixed in 4% para-
formaldehyde for 20 mins. Coverslips were then rinsed 3
times in PBS and aldehydes were quenched in 100 mM
glycine for 15 mins before rinsing 3 times in 0.2% fish skin
gelatine (made in PBS). Coverslips were then blocked in
Goat Serum (1:10, 0.2% FSG; Jackson ImmunoResearch
Europe) for 10 mins, and rinsed once in 0.2% FSG before
being incubated in primary antibodies [MyoD1 (Novo-
castra Laboratories) prepared according to the manufac-
turer's instructions at 1:50 or Myogenin/F5D at 1:50] for
20 mins at room temperature. Primary was rinsed 3 times
with 0.2% FSG before being placed in secondary [Alexa
Fluor 488 (Invitrogen) at 1:500, with DAPI at 1:1000 using
an 10 μg/μl stock]. Secondary was rinsed off 3 times with
0.2% FSG and 3 times in MiliQ water before being blotted
dry and mounted in Vectashield® Mounting Medium
Hamilton et al. BMC Cell Biology 2010, 11:37
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a fluorescent microscope. To analyze MyoD and Myo-
genin expression, 5 different fields were counted for
DAPI positive nuclei and MyoD/Myogenin positive
nuclei.
Statistics
All data are represented as mean ± standard error and
significance was determined using the Brightstat statisti-
cal package http://www.brightstat.com using ANOVA
with posthoc analysis by Tukey's Honestly Significant
Difference test.
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